About: covid:PMC7319703

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7319703 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Blackhall, Fiona Addeo, Alfredo Peters, Solange Reck, Martin Von Garnier, Christophe Dziadziuszko, Rafal Bouchaab, Hasna Felip, Enriqueta Passaro, Antonio Planchard, David de Marinis, Filippo
is schema:about of	named entity 'COVID-19' named entity 'clinical guide' named entity 'inflammatory' named entity 'PCI' named entity 'COVID' named entity 'radiation therapy' named entity 'infection' named entity 'tumour' named entity 'hypercalcaemia' named entity 'lung cancer' named entity 'COVID' named entity 'thoracentesis' named entity 'infection' named entity 'positron emission tomography scan' named entity 'SARS-CoV-2' named entity 'follow-up' named entity 'COVID-19 pandemic' named entity 'chemotherapy-induced' named entity 'neutropenic sepsis' named entity 'lung cancer' named entity 'pharmacological' named entity 'lung cancer' named entity 'Palliative' named entity 'haemoptysis' named entity 'COVID-19 pandemic' named entity 'adjuvant' named entity 'long-term' named entity 'radiotherapy' named entity 'radiotherapy' named entity 'dyspnoea' named entity 'cancer care' named entity 'chemotherapy' named entity 'intensive care unit' named entity 'SARS-CoV-2' named entity 'adjuvant chemotherapy' named entity 'adjuvant chemotherapy' named entity 'lung cancer' named entity 'infection' named entity 'neoadjuvant' named entity 'tyrosine kinase inhibitors' named entity 'oncologists' named entity 'medical treatments' named entity 'NSCLC' named entity 'stereotactic' named entity 'oncogene' named entity 'granulocyte' named entity 'MRI' named entity 'lung cancer screening' named entity 'chemotherapy' named entity 'durvalumab' named entity 'lung cancer' named entity 'MCBS' named entity 'neoadjuvant' named entity 'malignancy' named entity 'prognosis' named entity 'life-threatening' named entity 'personal protective equipment' named entity 'COVID-19 disease' named entity 'chemotherapy' named entity 'NSCLC' named entity 'infection' named entity 'infection' named entity 'immunotherapy' named entity 'COVID-19 pandemic' named entity 'COVID' named entity 'paraneoplastic syndromes' named entity 'National Health Service' named entity 'patient care' named entity 'oral chemotherapy' named entity 'immune suppression' named entity 'metastatic' named entity 'G-CSF' named entity 'SARS-CoV-2' named entity 'tyrosine kinase inhibitors' named entity 'radiotherapy' named entity 'Ontario' named entity 'second-line therapy' named entity 'comorbidities' named entity 'MRI' named entity 'G-CSF' named entity 'non-small cell lung cancer' named entity 'disease control' named entity 'evidence base' named entity 'COVID-19' named entity 'malignant' named entity 'morbidity' named entity 'prognosis' named entity 'cancer care' named entity 'mg30'

Attributes

Values

Creator

Blackhall, Fiona
Addeo, Alfredo
Peters, Solange
Reck, Martin
Von Garnier, Christophe
Dziadziuszko, Rafal
Bouchaab, Hasna
Felip, Enriqueta
Passaro, Antonio
Planchard, David
de Marinis, Filippo

is schema:about of

named entity 'COVID-19'
named entity 'clinical guide'
named entity 'inflammatory'
named entity 'PCI'
named entity 'COVID'
named entity 'radiation therapy'
named entity 'infection'
named entity 'tumour'
named entity 'hypercalcaemia'
named entity 'lung cancer'
named entity 'COVID'
named entity 'thoracentesis'
named entity 'infection'
named entity 'positron emission tomography scan'
named entity 'SARS-CoV-2'
named entity 'follow-up'
named entity 'COVID-19 pandemic'
named entity 'chemotherapy-induced'
named entity 'neutropenic sepsis'
named entity 'lung cancer'
named entity 'pharmacological'
named entity 'lung cancer'
named entity 'Palliative'
named entity 'haemoptysis'
named entity 'COVID-19 pandemic'
named entity 'adjuvant'
named entity 'long-term'
named entity 'radiotherapy'
named entity 'radiotherapy'
named entity 'dyspnoea'
named entity 'cancer care'
named entity 'chemotherapy'
named entity 'intensive care unit'
named entity 'SARS-CoV-2'
named entity 'adjuvant chemotherapy'
named entity 'adjuvant chemotherapy'
named entity 'lung cancer'
named entity 'infection'
named entity 'neoadjuvant'
named entity 'tyrosine kinase inhibitors'
named entity 'oncologists'
named entity 'medical treatments'
named entity 'NSCLC'
named entity 'stereotactic'
named entity 'oncogene'
named entity 'granulocyte'
named entity 'MRI'
named entity 'lung cancer screening'
named entity 'chemotherapy'
named entity 'durvalumab'
named entity 'lung cancer'
named entity 'MCBS'
named entity 'neoadjuvant'
named entity 'malignancy'
named entity 'prognosis'
named entity 'life-threatening'
named entity 'personal protective equipment'
named entity 'COVID-19 disease'
named entity 'chemotherapy'
named entity 'NSCLC'
named entity 'infection'
named entity 'infection'
named entity 'immunotherapy'
named entity 'COVID-19 pandemic'
named entity 'COVID'
named entity 'paraneoplastic syndromes'
named entity 'National Health Service'
named entity 'patient care'
named entity 'oral chemotherapy'
named entity 'immune suppression'
named entity 'metastatic'
named entity 'G-CSF'
named entity 'SARS-CoV-2'
named entity 'tyrosine kinase inhibitors'
named entity 'radiotherapy'
named entity 'Ontario'
named entity 'second-line therapy'
named entity 'comorbidities'
named entity 'MRI'
named entity 'G-CSF'
named entity 'non-small cell lung cancer'
named entity 'disease control'
named entity 'evidence base'
named entity 'COVID-19'
named entity 'malignant'
named entity 'morbidity'
named entity 'prognosis'
named entity 'cancer care'
named entity 'mg30'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software